Liraglutide
Drug ingredientActive ShortageCAS 204656-20-2
This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293719 · basket
These shares come from HS customs code 293719, which covers 53 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Switzerland
- Sweden
- India
- Spain
- Israel
- Austria
- Belgium
- Netherlands
- Italy
- Hong Kong
- Brazil
- United Kingdom
- Germany
- Canada
- Australia
- Japan
- New Zealand
- Latvia
- South Korea
- Taiwan
- Estonia
- Uruguay
37 FDA-registered drug labelers
Why It Matters
Appears in 4 drug and cosmetic product listings (FDA).
- •Liraglutide
- •Xultophy 100/3.6
- •Victoza
- •Saxenda
- Current shortage
Liraglutide Injection
Shortage listed since July 18, 2023
Manufacturer reports: 1 limited, 1 available
Chemical Identity
Data Sources
- PubChem · compound 16134956Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Liraglutide (CAS 204656-20-2) https://chemicalindependence.com/chemical/204656-20-2/ PubChem: 16134956. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/16134956 FDA National Drug Code directory: CAS 204656-20-2. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 204656-20-2. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293719 for CAS 204656-20-2. Reporting year: 2024. https://usatrade.census.gov/